REPORT FROM THE 9th INTERNATIONAL CONFERENCE AD/PD, PRAGUE, CZECH REPUBLIC, MARCH 11-15, 2009 – Genetic variants in HMG CoA reductase may influence the risk of Alzheimers disease, according to the results of a study of French Canadians from Eastern Canada (Legault et al. AD/PD; 1626).